Literature DB >> 31509005

Characterizing Covariant Trajectories of Individuals at Clinical High Risk for Psychosis Across Symptomatic and Functional Domains.

Dana M Allswede1, Jean Addington1, Carrie E Bearden1, Kristin S Cadenhead1, Barbara A Cornblatt1, Daniel H Mathalon1, Thomas McGlashan1, Diana O Perkins1, Larry J Seidman1, Ming T Tsuang1, Elaine F Walker1, Scott W Woods1, Tyrone D Cannon1.   

Abstract

OBJECTIVE: The authors sought to characterize differences in outcomes among help-seeking individuals at clinical high risk for psychosis by identifying covariant longitudinal patterns of symptoms and functioning.
METHODS: Group-based multitrajectory modeling was applied to longitudinal ratings of four symptom domains (positive, negative, disorganized, general) and general functioning among clinical high-risk individuals in an initial discovery sample (N=422). An independent sample (N=133) was used to test replicability.
RESULTS: Three trajectory groups were identified among clinical high-risk individuals in the discovery sample: group 1 (30%) exhibited substantial improvement across all domains, with half reaching positive outcomes for both functioning and positive symptoms; group 2 (49%) exhibited moderate impairments across domains, with approximately one-quarter meeting criteria for positive outcomes; the remaining participants (group 3; 22%) exhibited consistent levels of severe impairment across domains and did not experience positive outcomes. These trajectory groups and remission patterns were replicated in an independent sample.
CONCLUSIONS: Replicable subgroups of help-seeking clinical high-risk cases can be ascertained based on distinctive profiles of change over time in symptoms and functioning. Within each of the three identified subgroups, similar patterns of change (i.e., rapid, moderate, or no improvement) were observed across the four symptom domains and functioning. This consistency of change over time across domains within each subgroup is a novel observation supporting the syndrome consistency of clinical high-risk symptoms and signs. The observed trajectory subgroups are suggestive of different degrees of need for clinical interventions, ranging from minimal or supportive for about one-third of cases to increasingly intensive among the remainder.

Entities:  

Keywords:  Clinical High Risk; Outcome Studies; Psychosis

Mesh:

Year:  2019        PMID: 31509005      PMCID: PMC7002249          DOI: 10.1176/appi.ajp.2019.18111290

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  22 in total

1.  Staged Treatment in Early Psychosis: A sequential multiple assignment randomised trial of interventions for ultra high risk of psychosis patients.

Authors:  Barnaby Nelson; G Paul Amminger; Hok Pan Yuen; Nicky Wallis; Melissa J Kerr; Lisa Dixon; Cameron Carter; Rachel Loewy; Tara A Niendam; Martha Shumway; Sarah Morris; Julie Blasioli; Patrick D McGorry
Journal:  Early Interv Psychiatry       Date:  2017-07-18       Impact factor: 2.732

2.  North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research.

Authors:  Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Barbara Cornblatt; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming Tsuang; Elaine F Walker; Scott W Woods; Robert Heinssen
Journal:  Schizophr Bull       Date:  2007-01-25       Impact factor: 9.306

3.  Symptomatic and functional remission in patients with first-episode psychosis.

Authors:  S Verma; M Subramaniam; E Abdin; L Y Poon; S A Chong
Journal:  Acta Psychiatr Scand       Date:  2012-05-23       Impact factor: 6.392

4.  Group-based multi-trajectory modeling.

Authors:  Daniel S Nagin; Bobby L Jones; Valéria Lima Passos; Richard E Tremblay
Journal:  Stat Methods Med Res       Date:  2016-10-17       Impact factor: 3.021

5.  Symptomatic and functional remission of subjects at clinical high risk for psychosis: a 2-year naturalistic observational study.

Authors:  Tae Young Lee; Sung Nyun Kim; Christoph U Correll; Min Soo Byun; Euitae Kim; Joon Hwan Jang; Do-Hyung Kang; Je-Yeon Yun; Jun Soo Kwon
Journal:  Schizophr Res       Date:  2014-05-09       Impact factor: 4.939

6.  Clinical and functional characteristics of youth at clinical high-risk for psychosis who do not transition to psychosis.

Authors:  Jean Addington; Jacqueline Stowkowy; Lu Liu; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Carrie E Bearden; Daniel H Mathalon; Olga Santesteban-Echarri; Scott W Woods
Journal:  Psychol Med       Date:  2018-09-04       Impact factor: 7.723

7.  North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms.

Authors:  Jean Addington; Lu Liu; Lisa Buchy; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Carrie E Bearden; Daniel H Mathalon; Thomas H McGlashan
Journal:  J Nerv Ment Dis       Date:  2015-05       Impact factor: 2.254

Review 8.  Disorder, not just state of risk: meta-analysis of functioning and quality of life in people at high risk of psychosis.

Authors:  Paolo Fusar-Poli; Matteo Rocchetti; Alberto Sardella; Alessia Avila; Martina Brandizzi; Edgardo Caverzasi; Pierluigi Politi; Stephan Ruhrmann; Philip McGuire
Journal:  Br J Psychiatry       Date:  2015-09       Impact factor: 9.319

9.  An Individualized Risk Calculator for Research in Prodromal Psychosis.

Authors:  Tyrone D Cannon; Changhong Yu; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Barbara A Cornblatt; Robert Heinssen; Clark D Jeffries; Daniel H Mathalon; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Michael W Kattan
Journal:  Am J Psychiatry       Date:  2016-07-01       Impact factor: 18.112

10.  Self-awareness of functional impairment in individuals at clinical high-risk for psychosis.

Authors:  Doreen M Olvet; Ricardo E Carrión; Andrea M Auther; Barbara A Cornblatt
Journal:  Early Interv Psychiatry       Date:  2013-08-22       Impact factor: 2.732

View more
  8 in total

1.  Commentary. Toward a core outcomes assessment set for clinical high risk.

Authors:  Scott W Woods; Catalina V Mourgues-Codern; Albert R Powers
Journal:  Schizophr Res       Date:  2020-05-12       Impact factor: 4.939

Review 2.  Forecasting Remission From the Psychosis Risk Syndrome With Mismatch Negativity and P300: Potentials and Pitfalls.

Authors:  Holly K Hamilton; Brian J Roach; Daniel H Mathalon
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2020-10-24

3.  Individualized Prediction of Prodromal Symptom Remission for Youth at Clinical High Risk for Psychosis.

Authors:  Michelle A Worthington; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Barbara A Cornblatt; Matcheri Keshavan; Daniel H Mathalon; Thomas H McGlashan; Diana O Perkins; William S Stone; Ming T Tsuang; Elaine F Walker; Scott W Woods; Tyrone D Cannon
Journal:  Schizophr Bull       Date:  2022-03-01       Impact factor: 7.348

4.  Counterpoint. Early intervention for psychosis risk syndromes: Minimizing risk and maximizing benefit.

Authors:  Scott W Woods; Carrie E Bearden; Fred W Sabb; William S Stone; John Torous; Barbara A Cornblatt; Diana O Perkins; Kristin S Cadenhead; Jean Addington; Albert R Powers; Daniel H Mathalon; Monica E Calkins; Daniel H Wolf; Cheryl M Corcoran; Leslie E Horton; Vijay A Mittal; Jason Schiffman; Lauren M Ellman; Gregory P Strauss; Daniel Mamah; Jimmy Choi; Godfrey D Pearlson; Jai L Shah; Paolo Fusar-Poli; Celso Arango; Jesus Perez; Nikolaos Koutsouleris; Jijun Wang; Jun Soo Kwon; Barbara C Walsh; Thomas H McGlashan; Steven E Hyman; Raquel E Gur; Tyrone D Cannon; John M Kane; Alan Anticevic
Journal:  Schizophr Res       Date:  2020-05-10       Impact factor: 4.662

5.  Impact of Comorbid Affective Disorders on Longitudinal Clinical Outcomes in Individuals at Ultra-high Risk for Psychosis.

Authors:  Frederike Schirmbeck; Nadine C van der Burg; Matthijs Blankers; Jentien M Vermeulen; Philip McGuire; Lucia R Valmaggia; Matthew J Kempton; Mark van der Gaag; Anita Riecher-Rössler; Rodrigo A Bressan; Neus Barrantes-Vidal; Barnaby Nelson; G Paul Amminger; Patrick McGorry; Christos Pantelis; Marie-Odile Krebs; Stephan Ruhrmann; Gabriele Sachs; Bart P F Rutten; Jim van Os; Merete Nordentoft; Birte Glenthøj; Paolo Fusar-Poli; Lieuwe de Haan
Journal:  Schizophr Bull       Date:  2022-01-21       Impact factor: 9.306

6.  Application of the unified protocol for the transdiagnostic treatment of comorbid emotional disorders in patients with ultra-high risk of developing psychosis: A randomized trial study protocol.

Authors:  Trinidad Peláez; Raquel López-Carrillero; Marta Ferrer-Quintero; Susana Ochoa; Jorge Osma
Journal:  Front Psychol       Date:  2022-09-01

7.  Depression: An actionable outcome for those at clinical high-risk.

Authors:  Jean Addington; Megan S Farris; Lu Liu; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Carrie E Bearden; Daniel H Mathalon; William S Stone; Matcheri Keshevan; Scott W Woods
Journal:  Schizophr Res       Date:  2020-10-29       Impact factor: 4.939

8.  Time-course of clinical symptoms in young people at ultra-high risk for transition to psychosis.

Authors:  Anna Meneghelli; Angelo Cocchi; Maria Meliante; Simona Barbera; Lara Malvini; Emiliano Monzani; Antonio Preti; Mauro Percudani
Journal:  Early Interv Psychiatry       Date:  2021-07-22       Impact factor: 2.721

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.